- Diabetes Research
- Glucose Meters
- Adult Onset Diabetes
- Diabetes and Exercise
- Diabetes and Insurance
- Diabetes and Sex
- Diabetes Care
- Diabetes Control
- Diabetes Cure
- Diabetes Prevention
- Diabetes Technology
- Insulin Resistance
- Type 1 Diabetes
- Type 2 Diabetes
- Type 3 Diabetes
- Battle Diabetes
FDA approves inhaled insulin for type 1 and type 2 diabetes
The recent FDA approval of Afrezza, an inhaled insulin, could open up new options in mealtime insulin management for type 1 and type 2 diabetics, reports Health Day.
After being up for approval two previous times, the drug has now passed safety inspections that indicate Afrezza's efficacy and safety when combined with other diabetes therapies.
Patients with type 1 diabetes will need to pair Afrezza with long-acting insulin, while individuals with type 2 diabetes should use the drug in combination with oral diabetes medications.
Afrezza is the first inhaled medicine to be approved for diabetes treatment.
Afrezza not recommended for every diabetic
In a study involving more than 3,000 people - about 1,000 with type 1 diabetes and almost 2,000 with type 2 diabetes - Afrezza, when combined with either long-acting insulin or medication, produced better results than when Afrezza was used with a placebo.
"The agency stressed that Afrezza should never substitute for long-acting insulin, and patients with type 1 diabetes must use the drug in combination with long-acting insulin," Health Day's E.J. Mundell wrote. "Smokers should avoid Afrezza, as well, the agency said, and the drug is not to be used in the treatment of a condition called diabetic ketoacidosis."
Afrezza also isn't recommended for people with asthma.
According to Matthew Pfeffer, a spokesman for Afrezza's manufacturer MannKind, the cost of the inhalant will be priced comparably to fast-acting pen-based insulin therapies.
Source: Health Day, Web MD
Image credit: marin/FreeDigitalPhotos.net
The information provided on battlediabetes.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational and educational purposes. The publication of this information does not constitute the practice of medicine, and this information does not replace the advice of your physician or other health care provider. Neither the owners or employees of battlediabetes.com nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.